rampers get cranky with vcr down 7c., page-23

the ventracor baloney factory. Remember September 2003 when ABN AMRO were trying to get people to take up a 1:12 rights issue at $2.25 per share. Ventracor promised the trial on 10patients would be finished by DECEMBER 2003. Here we are 7mths later and struggling up to number 7 of 10.
Not good but contributed to people coughing up $2.25 per share. It was nonsense and an inappropriate prediction by Ventracor. A bad mistake by these people. How can you trust their predictions?

ABN AMRO said:


Near term milestones to maintain investor interest
Ventracor expects to have completed recruitment for its Pilot Trial by December
2003, which will involve implanting up to 10 devices. The aim of the Pilot Trial is
to ensure the device can be safely implanted, before moving to a global pivotal
trial, necessary to obtain approval to sell the devices. The medical investigating
team at The Alfred Hospital has advised that the first two implanted patients are
doing well.
52-week range: 3.81-0.63
S&P ASX 300: 3176.30
FTSE APxJP Health: 204.72
Health
Australia
Monday 29 September 2003 Flashnote